Observatory of Immunological Thrombopenic Purpura in the Brest Region

Observatory of Immunological Thrombopenic Purpura in the Brest Region: Descriptive and Comparative Cross-sectional Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06556888

Acronym

OPTIMIST

Enrollment

500

Registered

2024-08-16

Start date

2019-06-20

Completion date

2039-11-30

Last updated

2024-08-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune Thrombocytopenia

Brief summary

Database of patients with ITP, diagnosed, treated and followed in the Brest University Hospital.

Detailed description

Creation of a global clinical and biological database for all patients diagnosed, treated and followed for ITP in the University Hospital of Brest. UHB is the regional reference center (competence center) on hemorrhagic diseases. Dr Pan-Petesch, who is responsible of the local competence center, is affiliated to the national sector of auto-immune cytopenias CERECAI-MARIH).

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients with ITP agree to participate

Exclusion criteria

* Other thrombocythopenia other than ITP * Patients Under guardianship * Patients without national social security

Design outcomes

Primary

Measure	Time frame	Description
Description chronicity	1 year	Identification/description of risk factors of chronicity
Description treatment responses	1 year	Identification/ description of risk factors of bad responses

Countries

France

Contacts

Primary ContactBrigitte Pan-Petesch, MD

brigitte.pan-petesch@chu-brest.fr33298223650

Backup ContactVeronique Kouassi

veronique.kouassi@chu-brest.fr33298223333

Outcome results